Developer of a medical appointment scheduling platform designed to improve patient flow and back digitize healthcare pra
Developer of a medical appointment scheduling platform designed to improve patient flow and back digitize healthcare practices.
Other Healthcare Technology Systems📍 Warsaw, PolandFounded 2010
Current Valuation
$1.8B
as of 2021-Q3
UNICORN
QL Price
$1.8B
0% vs last round
QuantLogix's current estimate for ZnanyLekarz (Docplanner), published 2026-09-27 — in line with the last disclosed round of $1.8B (2021-Q3).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.8B
2021-Q3
weight 0.03
How this price has held up
No round has priced for ZnanyLekarz (Docplanner) since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, ZnanyLekarz (Docplanner), 2026-09-27 (c17f573fba41eb00).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is ZnanyLekarz (Docplanner) going public?
No. ZnanyLekarz (Docplanner) is private and has not filed to go public. There is no S-1 on file.
What is ZnanyLekarz (Docplanner)'s valuation in 2026?
ZnanyLekarz (Docplanner) is valued at $1.8B as of 2021-Q3, set by its Series F (Sep 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has ZnanyLekarz (Docplanner) filed an S-1?
No public S-1 is on file for ZnanyLekarz (Docplanner).
How much has ZnanyLekarz (Docplanner) raised?
ZnanyLekarz (Docplanner) has raised $143.67M in total, most recently a Series F in Sep 2021.
Is ZnanyLekarz (Docplanner) publicly traded — can you buy ZnanyLekarz (Docplanner) stock?
No. ZnanyLekarz (Docplanner) is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for ZnanyLekarz (Docplanner) on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2010
HQ
Warsaw, Poland
Employees
3,000
Total Raised
$143.67M
IPO Status
private
Fundraising Status
Series F · 5y ago
privateTotal raised $143.67M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
—
Sep 2021
—
$1.8B
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
26
via ashby
Product-build share
58%
engineering, research, product, design
Trajectory
steady
product-led hiring — 58% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Junior Software Engineer – Early Career (Strong Problem solving & Coding Focus) Senior Engineering Manager - Patient Engagement (100% Remote within Spain)Senior Engineering Manager - Patient Engagement (100% Remote within Poland)Senior Platform Security Engineer (100% Remote within Spain)Senior Platform Security Engineer (100% Remote within Poland)Junior Software Engineer – Early Career (Strong Problem solving & Coding Focus)
Counted from ZnanyLekarz (Docplanner)'s live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareSaaSMobile
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.